Syndax Pharmaceuticals Inc
SWB:1T3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Syndax Pharmaceuticals Inc
SWB:1T3
|
US |
|
Pluri Inc
F:Y55
|
IL |
|
Sonim Technologies Inc
F:2W9A
|
US |
|
New Zealand Oil and Gas Ltd
ASX:ECH
|
NZ |
|
Gallant Venture Ltd
OTC:GLVNF
|
SG |
Wall St Price Targets
1T3 Price Targets Summary
Syndax Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for 1T3 is 33.947 EUR with a low forecast of 22.41 EUR and a high forecast of 51.075 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1T3's stock price target?
Price Target
33.947
EUR
According to Wall Street analysts, the average 1-year price target for 1T3 is 33.947 EUR with a low forecast of 22.41 EUR and a high forecast of 51.075 EUR.
What is the Revenue forecast for Syndax Pharmaceuticals Inc?
Projected CAGR
34%
The compound annual growth rate for Revenue over the next 8 years is 34%.
What is the Gross Profit forecast for Syndax Pharmaceuticals Inc?
Projected CAGR
31%
The compound annual growth rate for Gross Profit over the next 8 years is 31%.
